OBJECTIVE: Development and validation of a simple and standardized self-reporting questionnaire for acute uncomplicated cystitis (AUC) assessing typical and differential symptoms, quality of life and possible changes after therapy in female patients with AUC. MATERIALS AND METHODS: Literature research, development and evaluation of the Acute Cystitis Symptom Score (ACSS), an 18-item self-reporting questionnaire including (a) six questions about 'typical' symptoms of AUC, (b) four questions regarding differential diagnoses, (c) three questions on quality of life and (d) five questions on additional conditions which may affect therapy. The ACSS was evaluated in 286 women (mean age 32.3 ± 12.3 years) in the Russian and Uzbek language. Measurements of reliability, validity, predictive ability and responsiveness were performed. RESULTS: Cronbach's alpha for the ACSS was 0.89, split-half reliability was 0.92 and correlation between halves was 0.85. Mann-Whitney test revealed significant difference scores of the 'typical' domain between patients and controls (10.75 vs. 2.02, p < 0.001). The optimal threshold score was 6 points, with a 94% sensitivity and 90% specificity to predict AUC. The symptom score decreased significantly when comparing before and after therapy (10.7 vs. 2.1, p < 0.001). CONCLUSION: The new validated ACSS is accurate enough and can be recommended for clinical studies and practice for initial diagnosis and monitoring treatment of AUC. Evaluation in other languages is in progress. 2014 S. Karger AG, Basel.
OBJECTIVE: Development and validation of a simple and standardized self-reporting questionnaire for acute uncomplicated cystitis (AUC) assessing typical and differential symptoms, quality of life and possible changes after therapy in female patients with AUC. MATERIALS AND METHODS: Literature research, development and evaluation of the Acute Cystitis Symptom Score (ACSS), an 18-item self-reporting questionnaire including (a) six questions about 'typical' symptoms of AUC, (b) four questions regarding differential diagnoses, (c) three questions on quality of life and (d) five questions on additional conditions which may affect therapy. The ACSS was evaluated in 286 women (mean age 32.3 ± 12.3 years) in the Russian and Uzbek language. Measurements of reliability, validity, predictive ability and responsiveness were performed. RESULTS: Cronbach's alpha for the ACSS was 0.89, split-half reliability was 0.92 and correlation between halves was 0.85. Mann-Whitney test revealed significant difference scores of the 'typical' domain between patients and controls (10.75 vs. 2.02, p < 0.001). The optimal threshold score was 6 points, with a 94% sensitivity and 90% specificity to predict AUC. The symptom score decreased significantly when comparing before and after therapy (10.7 vs. 2.1, p < 0.001). CONCLUSION: The new validated ACSS is accurate enough and can be recommended for clinical studies and practice for initial diagnosis and monitoring treatment of AUC. Evaluation in other languages is in progress. 2014 S. Karger AG, Basel.
Authors: Florian M Wagenlehner; Dimitri Abramov-Sommariva; Martina Höller; Hubert Steindl; Kurt G Naber Journal: Urol Int Date: 2018-09-19 Impact factor: 2.089
Authors: J F Alidjanov; A Pilatz; U A Abdufattaev; J Wiltink; W Weidner; K G Naber; F Wagenlehner Journal: Urologe A Date: 2015-09 Impact factor: 0.639
Authors: Jakhongir F Alidjanov; Kurt G Naber; Ulugbek A Abdufattaev; Adrian Pilatz; Florian M E Wagenlehner Journal: Antibiotics (Basel) Date: 2018-01-15
Authors: Jakhongir F Alidjanov; Ulugbek A Khudaybergenov; Bekhzod A Ayubov; Adrian Pilatz; Stefan Mohr; Julia C Münst; Olivia N Ziviello Yuen; Sabine Pilatz; Corina Christmann; Florian Dittmar; Nodir M Mirsaidov; Mareike Buch-Heberling; Kurt G Naber; Truls E Bjerklund Johansen; Florian M E Wagenlehner Journal: Int Urogynecol J Date: 2021-06-25 Impact factor: 2.894